Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Classical Hodgkin Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03527628
What this trial is testing

OPTmizing Advanced Stage HodgkIn LymphoMa patIentS Therapy

Who this might be right for
Classical Hodgkin LymphomaHodgkin Lymphoma (Category)Hodgkin Disease+1 more
King Abdullah International Medical Research Center 220
Testing effectiveness (Phase 2)Looking for participantsNCT06984146
What this trial is testing

Nivo40-AVD for Advanced Classic Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma, Adult
National Medical Research Radiological Centre of the Ministry of Health of Russia 54
Testing effectiveness (Phase 2)Looking for participantsNCT05949931
What this trial is testing

Pianzumab Combined With AVD Regimen in the Treatment of Newly-diagnosed Advanced Classic Hodgkin Lymphoma

Who this might be right for
Classic Hodgkin Lymphoma
Sun Yat-sen University 108
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06919679
What this trial is testing

Phase II Trial of BrECADD in HIV-Positive Patients With Advanced-Stage Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma (Category)
University of Cologne 35
Early research (Phase 1)UnknownNCT03657381
What this trial is testing

Phase Ⅰ Study to Evaluate the Safety and Tolerability of Using F520

Who this might be right for
Advanced Solid Tumor，Recurrent Solid Tumor，Lymphoma，Recurrent Lymphocyte Depleted Classical Hodgkin Lymphoma
Shandong New Time Pharmaceutical Co., LTD 75
Early research (Phase 1)Ended earlyNCT04254107
What this trial is testing

A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer

Who this might be right for
Non-small Cell Lung CancerGastric CarcinomaGastroesophageal Junction Carcinoma+9 more
Seagen Inc. 133
Not applicableStudy completedNCT05066555
What this trial is testing

Circulating Tumor DNA Genotyping for Biological Monitoring of Patients Treated in the FIL-Rouge Clinical Trial

Who this might be right for
Hodgkin Lymphoma
Fondazione Italiana Linfomi - ETS 100
Testing effectiveness (Phase 2)Study completedNCT03615664
What this trial is testing

The Efficacy of Salvage BGD With autoSCT Consolidation in Advanced Classical HL Patients Not Responding to ABVD

Who this might be right for
Hodgkin's Lymphoma
Polish Lymphoma Research Group 115
Large-scale testing (Phase 3)UnknownNCT02661503
What this trial is testing

HD21 for Advanced Stages

Who this might be right for
Classical Hodgkin Lymphoma
University of Cologne 1,500
Testing effectiveness (Phase 2)UnknownNCT05833984
What this trial is testing

Safety and Efficacy of IMM01 Plus Tislelizumab in Patients With Advanced Solid Tumors and Lymphomas

Who this might be right for
Solid TumorClassic Hodgkin Lymphoma
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 309
Testing effectiveness (Phase 2)Study completedNCT00654732
What this trial is testing

Combination Chemotherapy With or Without Rituximab in Treating Participants With Stage III-IV Classic Hodgkin Lymphoma

Who this might be right for
Classic Hodgkin LymphomaLugano Classification Stage III Hodgkin Lymphoma AJCC v8Lugano Classification Stage IV Hodgkin Lymphoma AJCC v8
M.D. Anderson Cancer Center 58
Large-scale testing (Phase 3)Ended earlyNCT03138499
What this trial is testing

Nivolumab Plus Brentuximab Vedotin Versus Brentuximab Vedotin Alone in Patients With Advanced Stage Classical Hodgkin Lymphoma, Who Are Relapsed/ Refractory or Who Are Not Eligible for Autologous Stem Cell Transplant,

Who this might be right for
Hodgkin's Disease
Bristol-Myers Squibb 23
Not applicableWithdrawnNCT00093678
What this trial is testing

Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer

Who this might be right for
CachexiaLymphomaMelanoma (Skin)+4 more
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06045195
What this trial is testing

Pembrolizumab in First-Line Treatment of Advanced-Stage Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
University of Cologne 40
Not applicableLooking for participantsNCT06796517
What this trial is testing

Immunotherapy in Lymphoma

Who this might be right for
Relapsed/refractory High Grade B Cell LymphomaHigh Grade B-cell LymphomaDiffuse Large B Cell Lymphoma Relapsed+2 more
Sung-Soo Park 72
Testing effectiveness (Phase 2)Study completedNCT01569204
What this trial is testing

Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
University of Cologne 100
Early research (Phase 1)Study completedNCT01561911
What this trial is testing

A Phase I Study of the Chimeric Anti-CD40 Monoclonal Antibody ChiLob 7/4 to Treat Advanced Malignancies Refractory to Conventional Anti-cancer Treatment

Who this might be right for
CancerNeoplasmsLymphoma+2 more
Cancer Research UK 29
Testing effectiveness (Phase 2)UnknownNCT03617666
What this trial is testing

Avelumab in the Frontline Treatment of Advanced Classical Hodgkin Lymphoma - a Window Study

Who this might be right for
Hodgkin Lymphoma
University College, London 49
Early research (Phase 1)Ended earlyNCT02408861
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Advanced Malignant Solid NeoplasmAnal CarcinomaHIV Infection+7 more
National Cancer Institute (NCI) 79
Early research (Phase 1)Ended earlyNCT02603419
What this trial is testing

Avelumab In Patients With Previously Treated Advanced Stage Classical Hodgkin's Lymphoma (JAVELIN HODGKINS)

Who this might be right for
Hodgkins Lymphoma
Pfizer 34
Next Page